Global Dermatological Therapeutics Market 2019-2028

MARKET OUTLOOK

According to the publisher, the global dermatological therapeutics market is expected to display a positive market trend over the forecast period of 2019-2028, exhibiting a CAGR of 7.90%.
Skin disease is one of the major factors responsible for the growing global disease burden, affecting millions of people around the world. This is expected to lead to an increase in the adoption of dermatological treatments, which, in turn, will propel the studied market growth. Also, the rise in awareness regarding disease origin and progression is creating opportunities for market growth.

Dermatological therapies are used to treat different types of skin conditions and disorders. But despite this, there are certain major side-effects associated with anti-infectives, corticosteroids, retinoids, and every other drug class, which are quite prominent than others. This is majorly hampering the growth of the dermatological therapeutics market. Furthermore, unawareness about dermatological diagnosis is another factor challenging this market’s growth.

REGIONAL OUTLOOK

The Middle East and Africa, Latin America, Europe, the Asia-Pacific, and North America together envelop the global dermatological therapeutics market.
North America leads the global market for dermatological therapeutics market, accounting for the largest share. The growth of this market is attributable to the expanding rate of occurrence of pores and skin diseases among people in the region. The United States is the greatest commercial center for dermatology drugs, followed by Canada. The rise in the demand for dermatological services in North America is driven by the rise in incidence of skin cancer, particularly melanoma. Another major factor fuelling the demand for these services is the increase in the geriatric population in the region. Thus, the increased demand for dermatological services is augmenting the growth of the North American dermatological therapeutics market.

COMPETITIVE OUTLOOK

The notable players in this market include Merck & Co, Glaxosmithkline Plc, Abbvie Inc, Pfizer Inc, Amgen Inc, Leo Pharma A/S, Almirall, Allergan, Bausch Health Companies Inc, Galderma, Novartis AG, AGI Dermatics, and Johnson & Johnson.
Novartis AG is a globally popular pharmaceutical company, with a major presence in diverse biopharmaceutical segments. One of its products in the dermatology segment, Cosentyx, is a prescription medicine used for treating adults with moderate to severe plaque psoriasis. The company has operations across Europe, North America, Latin America, the Asia-Pacific, and the Middle East and Africa. Novartis reported revenues worth $53,166 million for the fiscal year ended December 2018 (FY2018), which was an increase of 6% over the preceding year.

1. Global Dermatological Therapeutics Market - Summary

2. Industry Outlook

2.1. Market Definition
2.2. Key Insights
2.2.1. Asia-Pacific is Most Encouraging Regional Market
2.2.2. China is Leading Overall Market
2.2.3. Advancements in Biologics
2.2.4. Atopic Dermatitis is Anticipated to Grow at Highest CAGR
2.3. Porter's Five Forces Analysis
2.3.1. Threat of New Entrants
2.3.2. Threat of Substitute
2.3.3. Bargaining Power of Suppliers
2.3.4. Bargaining Power of Buyers
2.3.5. Threat of Competitive Rivalry
2.4. Impact of COVID-19 – Dermatological Therapeutics
2.5. Market Attractiveness Index
2.6. Vendor Scorecard
2.7. Market Drivers
2.7.1. Increasing Burden of Dermatological Diseases
2.8. Market Restraints
2.8.1. Grave Side-Effects for Certain Classes of Therapeutic Drugs
2.9. Market Opportunities
2.9.1. Rise in Awareness Levels of Disease Origin and Progression
2.10. Market Challenges
2.10.1. Unawareness Towards Dermatological Diagnosis

3. Global Dermatological Therapeutics Market Outlook - by Drug Class

3.1. Anti-Infectives
3.2. Corticosteroids
3.3. Anti-Acne
3.4. Calcineurin Inhibitors
3.5. Retinoids
3.6. Other Drug Classes

4. Global Dermatological Therapeutics Market Outlook - by Application

4.1. Alopecia
4.2. Herpes
4.3. Psoriasis
4.4. Rosacea
4.5. Atopic Dermatitis
4.6. Acne Vulgaris
4.7. Other Applications

5. Global Dermatological Therapeutics Market – Regional Outlook

5.1. North America
5.1.1. Market by Drug Class
5.1.2. Market by Application
5.1.3. Country Analysis
5.1.3.1. United States
5.1.3.2. Canada
5.2. Europe
5.2.1. Market by Drug Class
5.2.2. Market by Application
5.2.3. Country Analysis
5.2.3.1. United Kingdom
5.2.3.2. Germany
5.2.3.3. France
5.2.3.4. Spain
5.2.3.5. Italy
5.2.3.6. Russia
5.2.3.7. Rest of Europe
5.3. Asia-Pacific
5.3.1. Market by Drug Class
5.3.2. Market by Application
5.3.3. Country Analysis
5.3.3.1. China
5.3.3.2. Japan
5.3.3.3. India
5.3.3.4. South Korea
5.3.3.5. Asean Countries
5.3.3.6. Australia & New Zealand
5.3.3.7. Rest of Asia-Pacific
5.4. Latin America
5.4.1. Market by Drug Class
5.4.2. Market by Application
5.4.3. Country Analysis
5.4.3.1. Brazil
5.4.3.2. Mexico
5.4.3.3. Rest of Latin America
5.5. Middle East and Africa
5.5.1. Market by Drug Class
5.5.2. Market by Application
5.5.3. Country Analysis
5.5.3.1. United Arab Emirates
5.5.3.2. Turkey
5.5.3.3. Saudi Arabia
5.5.3.4. South Africa
5.5.3.5. Rest of Middle East & Africa

6. Competitive Landscape

6.1. Abbvie Inc
6.2. Allergan
6.3. Almirall
6.4. Amgen Inc
6.5. Bausch Health Companies Inc
6.6. Galderma
6.7. GlaxoSmithKline plc
6.8. Johnson & Johnson
6.9. Novartis Ag
6.10. Pfizer Inc
6.11. AGI Dermatics
6.12. Leo Pharma A/S
6.13. Merck & Co

7. Methodology & Scope

7.1. Research Scope & Deliverables
7.2. Sources of Data
7.3. Research Methodology

List of Tables

Table 1: Global Dermatological Therapeutics Market, by Geography, 2019-2028 (In $ Billion)
Table 2: Market Attractiveness Index
Table 3: Vendor Scorecard
Table 4: Global Dermatological Therapeutics Market, by Drug Class, 2019-2028 (In $ Billion)
Table 5: Global Dermatological Therapeutics Market, by Application, 2019-2028 (In $ Billion)
Table 6: Global Dermatological Therapeutics Market, by Geography, 2019-2028 (In $ Billion)
Table 7: North America Dermatological Therapeutics Market, by Country, 2019-2028 (In $ Billion)
Table 8: North America Dermatological Therapeutics Market, by Drug Class, 2019-2028 (In $ Billion)
Table 9: North America Dermatological Therapeutics Market, by Application, 2019-2028 (In $ Billion)
Table 10: Europe Dermatological Therapeutics Market, by Country, 2019-2028 (In $ Billion)
Table 11: Europe Dermatological Therapeutics Market, by Drug Class, 2019-2028 (In $ Billion)
Table 12: Europe Dermatological Therapeutics Market, by Application, 2019-2028 (In $ Billion)
Table 13: Asia-Pacific Dermatological Therapeutics Market, by Country, 2019-2028 (In $ Billion)
Table 14: Asia-Pacific Dermatological Therapeutics Market, by Drug Class, 2019-2028 (In $ Billion)
Table 15: Asia-Pacific Dermatological Therapeutics Market, by Application, 2019-2028 (In $ Billion)
Table 16: Latin America Dermatological Therapeutics Market, by Country, 2019-2028 (In $ Billion)
Table 17: Latin America Dermatological Therapeutics Market, by Drug Class, 2019-2028 (In $ Billion)
Table 18: Latin America Dermatological Therapeutics Market, by Application, 2019-2028 (In $ Billion)
Table 19: Middle East and Africa Dermatological Therapeutics Market, by Country, 2019-2028 (In $ Billion)
Table 20: Middle East and Africa Dermatological Therapeutics Market, by Drug Class, 2019-2028 (In $ Billion)
Table 21: Middle East and Africa Dermatological Therapeutics Market, by Application, 2019-2028 (In $ Billion)

List of Figures

Figure 1: Porter's Five Forces Analysis
Figure 2: Global Dermatological Therapeutics Market, by Anti-Infectives, 2019-2028 (In $ Billion)
Figure 3: Global Dermatological Therapeutics Market, by Corticosteroids, 2019-2028 (In $ Billion)
Figure 4: Global Dermatological Therapeutics Market, by Anti-Acne, 2019-2028 (In $ Billion)
Figure 5: Global Dermatological Therapeutics Market, by Calcineurin Inhibitors, 2019-2028 (In $ Billion)
Figure 6: Global Dermatological Therapeutics Market, by Retinoids, 2019-2028 (In $ Billion)
Figure 7: Global Dermatological Therapeutics Market, by Other Drug Classes, 2019-2028 (In $ Billion)
Figure 8: Global Dermatological Therapeutics Market, by Alopecia, 2019-2028 (In $ Billion)
Figure 9: Global Dermatological Therapeutics Market, by Herpes, 2019-2028 (In $ Billion)
Figure 10: Global Dermatological Therapeutics Market, by Psoriasis, 2019-2028 (In $ Billion)
Figure 11: Global Dermatological Therapeutics Market, by Rosacea, 2019-2028 (In $ Billion)
Figure 12: Global Dermatological Therapeutics Market, by Atopic Dermatitis 2019-2028 (In $ Billion)
Figure 13: Global Dermatological Therapeutics Market, by Acne Vulgaris, 2019-2028 (In $ Billion)
Figure 14: Global Dermatological Therapeutics Market, by Other Applications, 2019-2028 (In $ Billion)
Figure 15: Global Dermatological Therapeutics Market, Regional Outlook, 2019 & 2028 (In %)
Figure 16: United States Dermatological Therapeutics Market 2019-2028 (In $ Billion)
Figure 17: Canada Dermatological Therapeutics Market 2019-2028 (In $ Billion)
Figure 18: United Kingdom Dermatological Therapeutics Market 2019-2028 (In $ Billion)
Figure 19: Germany Dermatological Therapeutics Market 2019-2028 (In $ Billion)
Figure 20: France Dermatological Therapeutics Market 2019-2028 (In $ Billion)
Figure 21: Spain Dermatological Therapeutics Market 2019-2028 (In $ Billion)
Figure 22: Italy Dermatological Therapeutics Market 2019-2028 (In $ Billion)
Figure 23: Russia Dermatological Therapeutics Market 2019-2028 (In $ Billion)
Figure 24: Rest of Europe Dermatological Therapeutics Market 2019-2028 (In $ Billion)
Figure 25: China Dermatological Therapeutics Market 2019-2028 (In $ Billion)
Figure 26: Japan Dermatological Therapeutics Market 2019-2028 (In $ Billion)
Figure 27: India Dermatological Therapeutics Market 2019-2028 (In $ Billion)
Figure 28: South Korea Dermatological Therapeutics Market 2019-2028 (In $ Billion)
Figure 29: Asean Countries Dermatological Therapeutics Market 2019-2028 (In $ Billion)
Figure 30: Australia & New Zealand Dermatological Therapeutics Market 2019-2028 (In $ Billion)
Figure 31: Rest of Asia-Pacific Dermatological Therapeutics Market 2019-2028 (In $ Billion)
Figure 32: Brazil Dermatological Therapeutics Market 2019-2028 (In $ Billion)
Figure 33: Mexico Dermatological Therapeutics Market 2019-2028 (In $ Billion)
Figure 34: Rest of Latin America Dermatological Therapeutics Market 2019-2028 (In $ Billion)
Figure 35: United Arab Emirates Dermatological Therapeutics Market 2019-2028 (In $ Billion)
Figure 36: Turkey Dermatological Therapeutics Market 2019-2028 (In $ Billion)
Figure 37: Saudi Arabia Dermatological Therapeutics Market 2019-2028 (In $ Billion)
Figure 38: South Africa Dermatological Therapeutics Market 2019-2028 (In $ Billion)
Figure 39: Rest of Middle East and Africa Dermatological Therapeutics Market 2019-2028 (In $ Billion)

Companies Mentioned

A selection of companies mentioned in this report includes:

Abbvie Inc
Allergan
Almirall
Amgen Inc
Bausch Health Companies Inc
Galderma
GlaxoSmithKline plc
Johnson & Johnson
Novartis AG
Pfizer Inc
AGi Dermatics
Leo Pharma A/S
Merck & Co

Methodology

LOADING...

MARKET OUTLOOK

REGIONAL OUTLOOK

COMPETITIVE OUTLOOK

Table of Contents

Companies Mentioned

Methodology

Related Topics

Related Reports

Dermatological Therapeutics Market Research Report by Drug Class (Anti-Acne, Anti-Infectives, and Calcineurin Inhibitors), Application, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

Dermatological Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Dermatological Therapeutic Market, By Application, By Drug Class, By Geography - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Dermatological Therapeutics Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

Dermatological Therapeutics Market Size Outlook to 2028 - Growth Opportunities, Dermatological Therapeutics Market Insights, Companies, Market share by Types, Applications, and Countries